BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 3488856)

  • 1. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
    Gunn HC
    Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis.
    Gunn HC; Ryffel B
    Clin Exp Immunol; 1986 May; 64(2):234-42. PubMed ID: 3742874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice.
    Israel-Biet D; Noel LH; Bach MA; Dardenne M; Bach JF
    Clin Exp Immunol; 1983 Nov; 54(2):359-65. PubMed ID: 6360436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H; Terada E; Okudaira K
    Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Backcross analysis of genes linked to autoantibody production in New Zealand White mice.
    Vyse TJ; Morel L; Tanner FJ; Wakeland EK; Kotzin BL
    J Immunol; 1996 Sep; 157(6):2719-27. PubMed ID: 8805679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
    Sato MN; Minoprio P; Avrameas S; Ternynck T
    Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of FUT-175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB x NZW) F1 mice.
    Ikehara S; Shimamura K; Aoyama T; Fujii S; Hamashima Y
    Immunology; 1985 Aug; 55(4):595-600. PubMed ID: 4018844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.
    Friedmann D; Yachimovich N; Mostoslavsky G; Pewzner-Jung Y; Ben-Yehuda A; Rajewsky K; Eilat D
    J Immunol; 1999 Apr; 162(8):4406-16. PubMed ID: 10201976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of murine lupus autoantibodies to DNA by administration of muramyl dipeptide and syngeneic anti-DNA IgG.
    Zouali M; Jolivet M; Leclerc C; Ravisse P; Audibert F; Eyquem A; Chedio L
    J Immunol; 1985 Aug; 135(2):1091-6. PubMed ID: 3874227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
    Dong L; Ito S; Ishii KJ; Klinman DM
    Arthritis Rheum; 2005 Feb; 52(2):651-8. PubMed ID: 15692999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of life in female NZB/NZW (F1) hybrid mice by cyclosporin A.
    Jones MG; Harris G
    Clin Exp Immunol; 1985 Jan; 59(1):1-9. PubMed ID: 3882281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association between natural autoantibody responses to histones and DNA in murine lupus.
    Tokushige K; Kinoshita K; Hirose S; Shirai T
    Autoimmunity; 1992; 12(4):285-93. PubMed ID: 1391598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous autoimmune disease in (NZB x NZW)F1 mice is ameliorated by treatment with methimazole.
    Mozes E; Zinger H; Kohn LD; Singer DS
    J Clin Immunol; 1998 Mar; 18(2):106-13. PubMed ID: 9533654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.
    Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T
    Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diet enriched with eicosapentaenoic acid suppresses autoimmune nephritis in female (NZB x NZW) F1 mice.
    Prickett JD; Robinson DR; Steinberg AD
    Trans Assoc Am Physicians; 1982; 95():145-54. PubMed ID: 6304973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice.
    Bynoté KK; Hackenberg JM; Korach KS; Lubahn DB; Lane PH; Gould KA
    Genes Immun; 2008 Mar; 9(2):137-52. PubMed ID: 18200028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice.
    Tarkowski A; Gunnarsson K; Stålhandske T
    Immunology; 1986 Dec; 59(4):589-94. PubMed ID: 3804379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.